Outcomes
Scientific Publications
MIRACLE generates high-quality scientific knowledge on the genetic and molecular mechanisms of cardiovascular disease. Our findings are disseminated through peer-reviewed publications in leading international journals, contributing to advances in research, clinical understanding, and innovation. Below are publications arising from the project.
Conferences, scientific meetings and stakeholder events
MIRACLE actively disseminates its results through a wide range of international conferences, scientific meetings, and stakeholder events. Below is a selection of key dissemination activities demonstrating the visibility and reach of the project.
Selected Conferences and Scientific Events
MIRACLE results have been presented at major international conferences, including:
- ESC Congress 2025 – presentation on integrating transcriptomics and genomics to uncover mechanisms of atherosclerosis
- ESC Cardio Genomics Conference 2025 – presentations and posters on functional genomics and single-cell approaches in cardiovascular disease
- European Stroke Organisation Conference – dissemination of results related to stroke genetics
- European Atherosclerosis Society (EAS) Congress (2024 & 2025) – multiple presentations and posters
- Dutch Atherosclerosis Society (DAS) Meetings (2024 & 2025) – scientific presentations and networking
- Gordon Research Conference (GRC) on Atherosclerosis 2025 – presentation of functional genomics insights
- Cardiac Regeneration and Vascular Biology Conference – collaborative discussions on vascular biology
- EMBO Workshop on Enhanceropathies – sharing advances in functional genomics relevant to cardiovascular disease
- Finnish Society of Atherosclerosis Meeting 2025 – dissemination to national research and clinical communities
Workshops, Expert Meetings, and Scientific Networking
MIRACLE project partners have contributed to specialised workshops and expert-level meetings, including:
- 32nd International Stroke Genomics Workshop – updates on genetic discoveries
- Biostroke Meeting – collaboration discussions on inflammatory mechanisms in atherosclerosis
- 22nd Eibsee Meeting – presentation of novel targets identified in the project
- Smooth Muscle Cell (SMC) Meeting, Munich – presentation and discussion of vascular genomics data
Invited Talks and Seminar Series
MIRACLE results have been shared through invited lectures and institutional seminar series, including:
- CNIC Seminar Series (Madrid) – invited talk on genetic risk in coronary artery disease and collaboration meetings
- NHLI Vascular Sciences Lecture, Imperial College London – invited presentation and research exchange with international experts
Innovation and Stakeholder Engagement
MIRACLE has actively engaged with innovation ecosystems and stakeholders:
- EIC Cardiogenomics Tech-to-Market Event – presentation and pitching of project-related innovation concepts
- Biotech Booster Meeting (Amersfoort) – discussions on valorisation and translation of research results into potential applications
In addition, MIRACLE partners have participated in collaborative discussions and working groups involving academic and industry stakeholders to explore future research and innovation opportunities.
